The protective effect of Dexrazoxane on onco-Cardiology induced by anticancer agents other than anthracyclines
- Author:
Jing-Wen LUN
1
;
Yu-Jing LU
1
;
Qi-Rong FENG
1
;
Yu-Xi YUAN
2
;
Qiu-Ru LI
2
;
Hai-Shan ZHAO
3
Author Information
- Publication Type:Journal Article
- Keywords: acute toxicity; cardiac function indicators; chemotherapeutic drugs other than anthracyclines; Dexrazoxane; onco-Cardiology; tissue organ toxicity; zebrafish
- From: Chinese Pharmacological Bulletin 2022;38(12):1816-1822
- CountryChina
- Language:Chinese
- Abstract: Aim To evaluate the protective effect of Dexrazoxane(Dex)on onco-Cardiology caused by chemotherapeutic drugs other than anthracycline antitumor drugs using zebrafish embryos, including:cisplatin, paclitaxel, vincristine sulfate, 5-fluorouracil and cyclophosphamide. Methods Zebrafish embryos at 24 hpf(hours post-fertilization)were exposed to different concentrations of drugs. The survival rate and the overall animal morphology at 48 hpf, 72 hpf and 96 hpf were observed with a microscope. Heart rate, ventricular contraction fraction, ventricular volume, and cardiac output were measured and calculated by video recordings made with a VCD system. The protective effect of Dex was evaluated using the established model of onco-Cardiology induced by anti-tumor drugs other than anthracyclines. Results In terms of acute toxicity, cisplatin, vincristine sulfate, 5-fluorouracil and cyclophosphamide all significantly reduced the survival rate of zebrafish embryos. The LC50 value was 437.655, 25.538, 65.606 and 19.021 mmol·L-1, respectively. In addition to paclitaxel, the other four anti-tumor drugs all showed significant changes in overall animal morphology and cardiac function indicators. In the study of the protective effect of Dex on four kinds of tumor heart diseases except anthracyclines, only cisplatin had a significant protective effect, which could improve the cardiotoxicity caused by cisplatin. The optimal concentration of Dex was 80 μmol·L-1. Conclusions Zebrafish models of drug toxicity caused by cisplatin, vincristine sulfate, 5-fluorouracil, and cyclophosphamide is established, which proves that Dex only has a protective effect on the toxicity caused by cisplatin.
